Recommendations for the Submission of LOINC® Codes in Regulatory Applications to the US Food and Drug Administration: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 1, 2017
April 20, 2020
ce6835ad-0bdd-4e08-b063-0e7dc3ae34d1
Related Documents
Submitting Clinical Trial Datasets to Evaluate the Impact of Immunogenicity on the Pharmacokinetics of a Drug
Guidance DocumentJune 18, 2026Center for Drug Evaluation and Research
Submitting Continuous Glucose Monitoring Data in Clinical Trials
Guidance DocumentMay 6, 2026Center for Biologics Evaluation and Research
Submitting Patient-Reported Outcome Data in Cancer Clinical Trials
Guidance DocumentNovember 6, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.